Proxy Season 2018 Preview

Proxy season, the period during which many organizations hold annual shareholder meetings, is fast approaching. As most board of directors meet in April, preparing for proxy season 2018 is a major consideration for many board administrators.

Topics for Proxy Season 2018 Preview

Join moderator Francis Byrd and a panel of industry experts as he discusses several key issues to consider prior to the upcoming proxy season.

162M : How Does Legislation Affect 2018 and Beyond?
CEO Pay Ratio Disclosure : What Does it Mean to Your Board / Company?
Say-On Pay (SOP) : What Should We Say & How Should We Say It?
Shareholder Proposals : What Should the Board  Company Response Be?


Amy Borrus
Amy BorrusDeputy Director, Council of Institutional Investors
Amy Borrus is deputy director of the Council of Institutional Investors (CII), a nonprofit, nonpartisan U.S. association of employee benefit funds, state and local entities charged with investing public assets, foundations and endowments, with combined assets in excess of $3 trillion, that promotes good corporate governance and strong shareholder rights. CII’s associate members include a range of asset managers with more than $20 trillion in assets under management. Amy plays a lead role in developing CII strategy, policies on corporate governance and other issues and outreach to stakeholders and policymakers. She manages CII communications and speaks frequently on behalf of CII.
Blair Jones
Blair JonesExecutive Compensation, Semler Brossy
Blair Jones works with Board Compensation Committees to align executive compensation with the unique business, market, and talent characteristics of the company ensuring value to executives is balanced by value to the company and its shareholders. Her insights and expertise are informed by 25 years of experience helping companies improve their business performance. She has worked extensively across industries, including healthcare, retail, professional services and consumer products, and has particular depth of expertise working with companies in transitional stages.
Scott H. Kimpel
Scott H. KimpelPartner, Hunton & Williams
Scott H. Kimpel is a partner in the capital markets practice of Hunton & Williams LLP, resident in the Firm’s Washington DC office. He regularly advises clients across a broad sector of the economy facing sensitive reporting, compliance and enforcement matters before the Securities and Exchange Commission and other capital markets regulators. Scott’s practice encompasses a wide range of matters involving the securities laws, mergers and acquisitions, corporate governance, regulatory enforcement, administrative law and public policy. Before joining Hunton & Williams, Scott served on the Executive Staff of the SEC as Counsel to Commissioner Troy A. Paredes from 2008 to 2012.
Suzanne Rolon
Suzanne RolonDirector of Corporate Governance, Pfizer
Suzanne Rolon is Director, Corporate Governance at Pfizer where she is responsible for engaging with investors and other stakeholders on current and emerging governance issues. She is also responsible for overseeing all communications directed to the Board of Directors and managing the shareholder services function. She works as a member of the proxy development team and engages in negotiations with shareholder proponents and investors during the proxy season. Prior to Pfizer, Ms. Rolon worked for Delta Air Lines where she held positions in Investor Relations and Reservations Sales Training and Development. She is a member of the Society for Corporate Governance, the Council of Institutional Investors, and she serves on Computershare’s Client Advisory Board.

Recent Tweets

Ready to get started?
Schedule a live demo and discover the BoardBookit Difference.

Schedule Demo

Interested in Learning More?

Read the latest board governance resources from our blog.